Selected research
Market Analysis & Forecast
Global Personal Dosimetry Service Market Analysis and Forecast 2026-2032
Market perspective
The global Personal Dosimetry Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Personal Dosimetry Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Personal Dosimetry Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Personal Dosimetry Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Personal Dosimetry Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Personal Dosimetry Service include Landauer, Chiyoda Technol Corporation, Kinetics, Mirion, RadPro, Sanova, TÜV Rheinland, SCI and Centro de Dosimetría, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Personal Dosimetry Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Personal Dosimetry Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Personal Dosimetry Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Personal Dosimetry Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Personal Dosimetry Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Personal Dosimetry Service revenue, projected growth trends, production technology, application and end-user industry.
Personal Dosimetry Service Segment by Company
Landauer
Chiyoda Technol Corporation
Kinetics
Mirion
RadPro
Sanova
TÜV Rheinland
SCI
Centro de Dosimetría
ARPANSA
Sierra Radiation
IRS
Dental Directory
Personal Dosimetry Service Segment by Type
Badge Dosimetry
Thermoluminescent Dosimetry (TLD)
Optically Stimulated Luminescence (OSL)
Electronic Dosimeters
Others
Personal Dosimetry Service Segment by Application
Medical
Industrial
Research
Nuclear Facilities
Others
Personal Dosimetry Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personal Dosimetry Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Personal Dosimetry Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personal Dosimetry Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Personal Dosimetry Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Personal Dosimetry Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personal Dosimetry Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Badge Dosimetry
- Thermoluminescent Dosimetry (TLD)
- Optically Stimulated Luminescence (OSL)
- Electronic Dosimeters
- Others
Applications
- Medical
- Industrial
- Research
- Nuclear Facilities
- Others
Companies covered
- Landauer
- Chiyoda Technol Corporation
- Kinetics
- Mirion
- RadPro
- Sanova
- TÜV Rheinland
- SCI
- Centro de Dosimetría
- ARPANSA
- Sierra Radiation
- IRS
- Dental Directory
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Personal Dosimetry Service Market by Type
- 1.2.1 Global Personal Dosimetry Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Badge Dosimetry
- 1.2.3 Thermoluminescent Dosimetry (TLD)
- 1.2.4 Optically Stimulated Luminescence (OSL)
- 1.2.5 Electronic Dosimeters
- 1.2.6 Others
- 1.3 Personal Dosimetry Service Market by Application
- 1.3.1 Global Personal Dosimetry Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical
- 1.3.3 Industrial
- 1.3.4 Research
- 1.3.5 Nuclear Facilities
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Personal Dosimetry Service Market Dynamics
- 2.1 Personal Dosimetry Service Industry Trends
- 2.2 Personal Dosimetry Service Industry Drivers
- 2.3 Personal Dosimetry Service Industry Opportunities and Challenges
- 2.4 Personal Dosimetry Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Personal Dosimetry Service Market Perspective (2021-2032)
- 3.2 Global Personal Dosimetry Service Growth Trends by Region
- 3.2.1 Global Personal Dosimetry Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Personal Dosimetry Service Market Size by Region (2021-2026)
- 3.2.3 Global Personal Dosimetry Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Personal Dosimetry Service Revenue by Players
- 4.1.1 Global Personal Dosimetry Service Revenue by Players (2021-2026)
- 4.1.2 Global Personal Dosimetry Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Personal Dosimetry Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Personal Dosimetry Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Personal Dosimetry Service Key Players Headquarters & Area Served
- 4.4 Global Personal Dosimetry Service Players, Product Type & Application
- 4.5 Global Personal Dosimetry Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Personal Dosimetry Service Market CR5 and HHI
- 4.6.3 2025 Personal Dosimetry Service Tier 1, Tier 2, and Tier 3
5 Personal Dosimetry Service Market Size by Type
- 5.1 Global Personal Dosimetry Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Personal Dosimetry Service Revenue by Type (2021-2032)
- 5.3 Global Personal Dosimetry Service Revenue Market Share by Type (2021-2032)
6 Personal Dosimetry Service Market Size by Application
- 6.1 Global Personal Dosimetry Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Personal Dosimetry Service Revenue by Application (2021-2032)
- 6.3 Global Personal Dosimetry Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Landauer
- 7.1.1 Landauer Company Information
- 7.1.2 Landauer Business Overview
- 7.1.3 Landauer Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Landauer Personal Dosimetry Service Product Portfolio
- 7.1.5 Landauer Recent Developments
- 7.2 Chiyoda Technol Corporation
- 7.2.1 Chiyoda Technol Corporation Company Information
- 7.2.2 Chiyoda Technol Corporation Business Overview
- 7.2.3 Chiyoda Technol Corporation Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Chiyoda Technol Corporation Personal Dosimetry Service Product Portfolio
- 7.2.5 Chiyoda Technol Corporation Recent Developments
- 7.3 Kinetics
- 7.3.1 Kinetics Company Information
- 7.3.2 Kinetics Business Overview
- 7.3.3 Kinetics Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Kinetics Personal Dosimetry Service Product Portfolio
- 7.3.5 Kinetics Recent Developments
- 7.4 Mirion
- 7.4.1 Mirion Company Information
- 7.4.2 Mirion Business Overview
- 7.4.3 Mirion Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Mirion Personal Dosimetry Service Product Portfolio
- 7.4.5 Mirion Recent Developments
- 7.5 RadPro
- 7.5.1 RadPro Company Information
- 7.5.2 RadPro Business Overview
- 7.5.3 RadPro Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.5.4 RadPro Personal Dosimetry Service Product Portfolio
- 7.5.5 RadPro Recent Developments
- 7.6 Sanova
- 7.6.1 Sanova Company Information
- 7.6.2 Sanova Business Overview
- 7.6.3 Sanova Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Sanova Personal Dosimetry Service Product Portfolio
- 7.6.5 Sanova Recent Developments
- 7.7 TÜV Rheinland
- 7.7.1 TÜV Rheinland Company Information
- 7.7.2 TÜV Rheinland Business Overview
- 7.7.3 TÜV Rheinland Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.7.4 TÜV Rheinland Personal Dosimetry Service Product Portfolio
- 7.7.5 TÜV Rheinland Recent Developments
- 7.8 SCI
- 7.8.1 SCI Company Information
- 7.8.2 SCI Business Overview
- 7.8.3 SCI Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.8.4 SCI Personal Dosimetry Service Product Portfolio
- 7.8.5 SCI Recent Developments
- 7.9 Centro de Dosimetría
- 7.9.1 Centro de Dosimetría Company Information
- 7.9.2 Centro de Dosimetría Business Overview
- 7.9.3 Centro de Dosimetría Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Centro de Dosimetría Personal Dosimetry Service Product Portfolio
- 7.9.5 Centro de Dosimetría Recent Developments
- 7.10 ARPANSA
- 7.10.1 ARPANSA Company Information
- 7.10.2 ARPANSA Business Overview
- 7.10.3 ARPANSA Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.10.4 ARPANSA Personal Dosimetry Service Product Portfolio
- 7.10.5 ARPANSA Recent Developments
- 7.11 Sierra Radiation
- 7.11.1 Sierra Radiation Company Information
- 7.11.2 Sierra Radiation Business Overview
- 7.11.3 Sierra Radiation Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Sierra Radiation Personal Dosimetry Service Product Portfolio
- 7.11.5 Sierra Radiation Recent Developments
- 7.12 IRS
- 7.12.1 IRS Company Information
- 7.12.2 IRS Business Overview
- 7.12.3 IRS Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.12.4 IRS Personal Dosimetry Service Product Portfolio
- 7.12.5 IRS Recent Developments
- 7.13 Dental Directory
- 7.13.1 Dental Directory Company Information
- 7.13.2 Dental Directory Business Overview
- 7.13.3 Dental Directory Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Dental Directory Personal Dosimetry Service Product Portfolio
- 7.13.5 Dental Directory Recent Developments
8 North America
- 8.1 North America Personal Dosimetry Service Revenue (2021-2032)
- 8.2 North America Personal Dosimetry Service Revenue by Type (2021-2032)
- 8.2.1 North America Personal Dosimetry Service Revenue by Type (2021-2026)
- 8.2.2 North America Personal Dosimetry Service Revenue by Type (2027-2032)
- 8.3 North America Personal Dosimetry Service Revenue Share by Type (2021-2032)
- 8.4 North America Personal Dosimetry Service Revenue by Application (2021-2032)
- 8.4.1 North America Personal Dosimetry Service Revenue by Application (2021-2026)
- 8.4.2 North America Personal Dosimetry Service Revenue by Application (2027-2032)
- 8.5 North America Personal Dosimetry Service Revenue Share by Application (2021-2032)
- 8.6 North America Personal Dosimetry Service Revenue by Country
- 8.6.1 North America Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Personal Dosimetry Service Revenue by Country (2021-2026)
- 8.6.3 North America Personal Dosimetry Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Personal Dosimetry Service Revenue (2021-2032)
- 9.2 Europe Personal Dosimetry Service Revenue by Type (2021-2032)
- 9.2.1 Europe Personal Dosimetry Service Revenue by Type (2021-2026)
- 9.2.2 Europe Personal Dosimetry Service Revenue by Type (2027-2032)
- 9.3 Europe Personal Dosimetry Service Revenue Share by Type (2021-2032)
- 9.4 Europe Personal Dosimetry Service Revenue by Application (2021-2032)
- 9.4.1 Europe Personal Dosimetry Service Revenue by Application (2021-2026)
- 9.4.2 Europe Personal Dosimetry Service Revenue by Application (2027-2032)
- 9.5 Europe Personal Dosimetry Service Revenue Share by Application (2021-2032)
- 9.6 Europe Personal Dosimetry Service Revenue by Country
- 9.6.1 Europe Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Personal Dosimetry Service Revenue by Country (2021-2026)
- 9.6.3 Europe Personal Dosimetry Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Personal Dosimetry Service Revenue (2021-2032)
- 10.2 China Personal Dosimetry Service Revenue by Type (2021-2032)
- 10.2.1 China Personal Dosimetry Service Revenue by Type (2021-2026)
- 10.2.2 China Personal Dosimetry Service Revenue by Type (2027-2032)
- 10.3 China Personal Dosimetry Service Revenue Share by Type (2021-2032)
- 10.4 China Personal Dosimetry Service Revenue by Application (2021-2032)
- 10.4.1 China Personal Dosimetry Service Revenue by Application (2021-2026)
- 10.4.2 China Personal Dosimetry Service Revenue by Application (2027-2032)
- 10.5 China Personal Dosimetry Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Personal Dosimetry Service Revenue (2021-2032)
- 11.2 Asia Personal Dosimetry Service Revenue by Type (2021-2032)
- 11.2.1 Asia Personal Dosimetry Service Revenue by Type (2021-2026)
- 11.2.2 Asia Personal Dosimetry Service Revenue by Type (2027-2032)
- 11.3 Asia Personal Dosimetry Service Revenue Share by Type (2021-2032)
- 11.4 Asia Personal Dosimetry Service Revenue by Application (2021-2032)
- 11.4.1 Asia Personal Dosimetry Service Revenue by Application (2021-2026)
- 11.4.2 Asia Personal Dosimetry Service Revenue by Application (2027-2032)
- 11.5 Asia Personal Dosimetry Service Revenue Share by Application (2021-2032)
- 11.6 Asia Personal Dosimetry Service Revenue by Country
- 11.6.1 Asia Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Personal Dosimetry Service Revenue by Country (2021-2026)
- 11.6.3 Asia Personal Dosimetry Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Personal Dosimetry Service Revenue (2021-2032)
- 12.2 SAMEA Personal Dosimetry Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Personal Dosimetry Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Personal Dosimetry Service Revenue by Type (2027-2032)
- 12.3 SAMEA Personal Dosimetry Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Personal Dosimetry Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Personal Dosimetry Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Personal Dosimetry Service Revenue by Application (2027-2032)
- 12.5 SAMEA Personal Dosimetry Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Personal Dosimetry Service Revenue by Country
- 12.6.1 SAMEA Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Personal Dosimetry Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Personal Dosimetry Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst